Akute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellulären Karzinom mit reduziertem Gesamtüberleben assoziiert

Translated title of the contribution: Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma

Hwa Kyung Byun, Nalee Kim, Sangjoon Park, Jinsil Seong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Radiotherapy (RT) for peripheral organs can affect circulating lymphocytes and cause lymphopenia. We aimed to investigate RT-related lymphopenia in patients with hepatocellular carcinoma (HCC). Methods: Medical records of 920 patients who received RT for HCC during 2001–2016 were reviewed. Total lymphocyte count (TLC) were obtained and analyzed for clinical outcome. Acute severe lymphopenia (ASL) was defined as TLC <500/μL within the first 3 months of the start of RT. Results: The median TLCs before and 1 month after the start of RT were 1120 and 310/μl, respectively, and the TLCs did not recover to their initial level after 1 year. Overall, 87.4% of patients developed ASL. The median overall survival was 13.6 and 46.7 months for patients with and without ASL, respectively (p < 0.001). ASL was independently associated with poor overall survival with a hazard ratio (HR) of 1.40; 95% confidence interval (CI), 1.02–1.91 (p = 0.035). In the multivariate analysis, larger planning target volume (HR, 1.02; 95% CI, 1.01–1.03; p < 0.001) and lower baseline TLC (HR, 0.86; 95% CI, 0.82–0.91; p < 0.001) were significantly associated with an increased risk of ASL, while hypofractionation (stereotactic body RT: HR, 0.19; 95% CI, 0.07–0.49; p = 0.001) was significantly associated with a reduced risk of ASL. Conclusion: Acute severe lymphopenia after RT was associated with poor overall survival in patients with HCC. Stereotactic body RT may reduce the risk of ASL. Further attention to and research on the cause, prevention, and reversal of this phenomenon are needed.

Original languageGerman
Pages (from-to)1007-1017
Number of pages11
JournalStrahlentherapie und Onkologie
Volume195
Issue number11
DOIs
Publication statusPublished - 2019 Nov 1

Fingerprint

Lymphopenia
Hepatocellular Carcinoma
Radiotherapy
Survival
Lymphocyte Count
Confidence Intervals
Radiosurgery
Medical Records
Multivariate Analysis
Lymphocytes

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

@article{dabc056164194be58e9123e02d98e62e,
title = "Akute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellul{\"a}ren Karzinom mit reduziertem Gesamt{\"u}berleben assoziiert",
abstract = "Purpose: Radiotherapy (RT) for peripheral organs can affect circulating lymphocytes and cause lymphopenia. We aimed to investigate RT-related lymphopenia in patients with hepatocellular carcinoma (HCC). Methods: Medical records of 920 patients who received RT for HCC during 2001–2016 were reviewed. Total lymphocyte count (TLC) were obtained and analyzed for clinical outcome. Acute severe lymphopenia (ASL) was defined as TLC <500/μL within the first 3 months of the start of RT. Results: The median TLCs before and 1 month after the start of RT were 1120 and 310/μl, respectively, and the TLCs did not recover to their initial level after 1 year. Overall, 87.4{\%} of patients developed ASL. The median overall survival was 13.6 and 46.7 months for patients with and without ASL, respectively (p < 0.001). ASL was independently associated with poor overall survival with a hazard ratio (HR) of 1.40; 95{\%} confidence interval (CI), 1.02–1.91 (p = 0.035). In the multivariate analysis, larger planning target volume (HR, 1.02; 95{\%} CI, 1.01–1.03; p < 0.001) and lower baseline TLC (HR, 0.86; 95{\%} CI, 0.82–0.91; p < 0.001) were significantly associated with an increased risk of ASL, while hypofractionation (stereotactic body RT: HR, 0.19; 95{\%} CI, 0.07–0.49; p = 0.001) was significantly associated with a reduced risk of ASL. Conclusion: Acute severe lymphopenia after RT was associated with poor overall survival in patients with HCC. Stereotactic body RT may reduce the risk of ASL. Further attention to and research on the cause, prevention, and reversal of this phenomenon are needed.",
author = "Byun, {Hwa Kyung} and Nalee Kim and Sangjoon Park and Jinsil Seong",
year = "2019",
month = "11",
day = "1",
doi = "10.1007/s00066-019-01462-5",
language = "German",
volume = "195",
pages = "1007--1017",
journal = "Strahlentherapie und Onkologie",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "11",

}

Akute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellulären Karzinom mit reduziertem Gesamtüberleben assoziiert. / Byun, Hwa Kyung; Kim, Nalee; Park, Sangjoon; Seong, Jinsil.

In: Strahlentherapie und Onkologie, Vol. 195, No. 11, 01.11.2019, p. 1007-1017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Akute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellulären Karzinom mit reduziertem Gesamtüberleben assoziiert

AU - Byun, Hwa Kyung

AU - Kim, Nalee

AU - Park, Sangjoon

AU - Seong, Jinsil

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Purpose: Radiotherapy (RT) for peripheral organs can affect circulating lymphocytes and cause lymphopenia. We aimed to investigate RT-related lymphopenia in patients with hepatocellular carcinoma (HCC). Methods: Medical records of 920 patients who received RT for HCC during 2001–2016 were reviewed. Total lymphocyte count (TLC) were obtained and analyzed for clinical outcome. Acute severe lymphopenia (ASL) was defined as TLC <500/μL within the first 3 months of the start of RT. Results: The median TLCs before and 1 month after the start of RT were 1120 and 310/μl, respectively, and the TLCs did not recover to their initial level after 1 year. Overall, 87.4% of patients developed ASL. The median overall survival was 13.6 and 46.7 months for patients with and without ASL, respectively (p < 0.001). ASL was independently associated with poor overall survival with a hazard ratio (HR) of 1.40; 95% confidence interval (CI), 1.02–1.91 (p = 0.035). In the multivariate analysis, larger planning target volume (HR, 1.02; 95% CI, 1.01–1.03; p < 0.001) and lower baseline TLC (HR, 0.86; 95% CI, 0.82–0.91; p < 0.001) were significantly associated with an increased risk of ASL, while hypofractionation (stereotactic body RT: HR, 0.19; 95% CI, 0.07–0.49; p = 0.001) was significantly associated with a reduced risk of ASL. Conclusion: Acute severe lymphopenia after RT was associated with poor overall survival in patients with HCC. Stereotactic body RT may reduce the risk of ASL. Further attention to and research on the cause, prevention, and reversal of this phenomenon are needed.

AB - Purpose: Radiotherapy (RT) for peripheral organs can affect circulating lymphocytes and cause lymphopenia. We aimed to investigate RT-related lymphopenia in patients with hepatocellular carcinoma (HCC). Methods: Medical records of 920 patients who received RT for HCC during 2001–2016 were reviewed. Total lymphocyte count (TLC) were obtained and analyzed for clinical outcome. Acute severe lymphopenia (ASL) was defined as TLC <500/μL within the first 3 months of the start of RT. Results: The median TLCs before and 1 month after the start of RT were 1120 and 310/μl, respectively, and the TLCs did not recover to their initial level after 1 year. Overall, 87.4% of patients developed ASL. The median overall survival was 13.6 and 46.7 months for patients with and without ASL, respectively (p < 0.001). ASL was independently associated with poor overall survival with a hazard ratio (HR) of 1.40; 95% confidence interval (CI), 1.02–1.91 (p = 0.035). In the multivariate analysis, larger planning target volume (HR, 1.02; 95% CI, 1.01–1.03; p < 0.001) and lower baseline TLC (HR, 0.86; 95% CI, 0.82–0.91; p < 0.001) were significantly associated with an increased risk of ASL, while hypofractionation (stereotactic body RT: HR, 0.19; 95% CI, 0.07–0.49; p = 0.001) was significantly associated with a reduced risk of ASL. Conclusion: Acute severe lymphopenia after RT was associated with poor overall survival in patients with HCC. Stereotactic body RT may reduce the risk of ASL. Further attention to and research on the cause, prevention, and reversal of this phenomenon are needed.

UR - http://www.scopus.com/inward/record.url?scp=85064572411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064572411&partnerID=8YFLogxK

U2 - 10.1007/s00066-019-01462-5

DO - 10.1007/s00066-019-01462-5

M3 - Article

C2 - 30989242

AN - SCOPUS:85064572411

VL - 195

SP - 1007

EP - 1017

JO - Strahlentherapie und Onkologie

JF - Strahlentherapie und Onkologie

SN - 0179-7158

IS - 11

ER -